Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI

Richter, Johan; Lübking, Anna; Söderlund, Stina; Lotfi, Kourosh; Markevärn, Berit; Själander, Anders; Stenke, Leif; Deneberg, Stefan; Ahlstrand, Erik; Myhr-Eriksson, Kristina; Panayiotidis, Panayiotis; Gedde-Dahl, Tobias; Žáčková, Daniela; Mayer, Jiří; Olsson-Strömberg, Ulla; Mahon, Francois-Xavier; Saussele, Susanne; Hjorth-Hansen, Henrik; Koskenvesa, Perttu
Peer reviewed, Journal article
Published version
Thumbnail
View/Open
URI
https://hdl.handle.net/11250/3043390
Date
2021
Metadata
Show full item record
Collections
Original version
Leukemia. 2021, 35 2416-2418.   10.1038/s41375-021-01173-w
Publisher
Springer
Journal
Leukemia
Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal